LifeStance Health Group (NASDAQ:LFST) Shares Gap Up to $6.18

LifeStance Health Group, Inc. (NASDAQ:LFST) shares gapped up prior to trading on Monday . The stock had previously closed at $6.18, but opened at $6.40. LifeStance Health Group shares last traded at $6.49, with a volume of 322,555 shares changing hands.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Barclays dropped their target price on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a report on Friday, August 9th. UBS Group lowered their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, August 15th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $8.25.

LifeStance Health Group Stock Down 2.9 %

The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18. The business has a 50 day moving average of $5.49 and a 200 day moving average of $6.06. The firm has a market capitalization of $2.40 billion, a price-to-earnings ratio of -13.06 and a beta of 1.20.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $312.30 million during the quarter, compared to analyst estimates of $305.85 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The firm’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same period last year, the company posted ($0.13) earnings per share. On average, equities analysts anticipate that LifeStance Health Group, Inc. will post -0.25 EPS for the current year.

Insiders Place Their Bets

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total transaction of $33,089.32. Following the completion of the sale, the insider now owns 263,007 shares in the company, valued at approximately $1,651,683.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Danish J. Qureshi sold 150,000 shares of the company’s stock in a transaction that occurred on Friday, June 14th. The shares were sold at an average price of $5.21, for a total value of $781,500.00. Following the completion of the transaction, the insider now owns 439,002 shares in the company, valued at $2,287,200.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ann Varanakis sold 5,269 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total transaction of $33,089.32. Following the sale, the insider now owns 263,007 shares in the company, valued at $1,651,683.96. The disclosure for this sale can be found here. In the last three months, insiders sold 240,362 shares of company stock valued at $1,285,154. 6.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On LifeStance Health Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Brown Advisory Inc. boosted its position in shares of LifeStance Health Group by 25.9% during the fourth quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock worth $40,395,000 after buying an additional 1,062,887 shares during the period. Point72 Asset Management L.P. bought a new position in shares of LifeStance Health Group during the second quarter worth about $4,326,000. Dimensional Fund Advisors LP grew its holdings in shares of LifeStance Health Group by 82.0% during the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock worth $4,991,000 after buying an additional 457,930 shares in the last quarter. Magnetar Financial LLC bought a new position in shares of LifeStance Health Group during the second quarter worth about $762,000. Finally, TD Asset Management Inc bought a new position in shares of LifeStance Health Group during the second quarter worth about $623,000. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.